# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Mitochondrial disorders

Mitochondrial genetic disordersMitochondrial diseases
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 239 results.
Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
Status: Active, not recruiting
Last Changed: Jun 22, 2020
First Received: Feb 02, 2015
Disease(s): Leigh Syndrome
Intervention(s): EPI-743
Locations: Gregory Enns, Stanford University, California, United States
Akron Children's Hospital, Akron, Ohio, United States
Baylor College of Medicine, Houston, Texas, United States
Seattle Children's Hospital, Seattle, Washington, United States
Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome
Status: Completed
Last Changed: Aug 31, 2020
First Received: Nov 06, 2012
Disease(s): Leigh Syndrome
Intervention(s): Placebo, EPI-743 15 mg/kg, EPI-743 5 mg/kg
Locations: Stanford University, Palo Alto, California, United States
Akron Children's Hospital, Akron, Ohio, United States
Baylor College of Medicine, Houston, Texas, United States
Seattle Children's Hospital, Seattle, Washington, United States
Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
Status: Unknown status
Last Changed: Jun 24, 2005
First Received: Sep 11, 2003
Disease(s): MELAS Syndrome
Intervention(s): Dichloroacetate
Locations: New York Presbyterian Hospital, New York City, New York, United States
A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Extension
Status: Terminated
Last Changed: Apr 24, 2020
First Received: Oct 27, 2017
Disease(s): Primary Mitochondrial Myopathy
Intervention(s): elamipretide, placebo comparator, elamipretide open label treatment
Locations: University of California San Diego, La Jolla, California, United States
Stanford University, Palo Alto, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Rare Disease Research, LLC, Atlanta, Georgia, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
... and 23 other locations.
Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Status: Completed
Last Changed: Jun 23, 2015
First Received: Dec 03, 2013
Disease(s): Phelan-McDermid Syndrome
Locations: Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States
Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation Disorders
Status: Completed
Last Changed: Nov 27, 2019
First Received: Nov 02, 2018
Disease(s): Mitochondrial Myopathies, Fatty Acid Oxidation Defects
Intervention(s): Resveratrol
Locations: Copenhagen Neuromuscular Center, Copenhagen, Denmark
Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)
Status: Recruiting
Last Changed: Aug 24, 2020
First Received: Aug 10, 2018
Disease(s): Leukoencephalopathies, LBSL, Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation, White Matter Disease, Ataxia, Cerebellar, Genetic Disease
Locations: Hugo Moser Center for Leukodystrophies, Baltimore, Maryland, United States
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Status: Unknown status
Last Changed: May 19, 2009
First Received: Apr 06, 2007
Disease(s): Mitochondrial Myopathy
Intervention(s): Exercise
Locations: University of Texas Southwestern Medical Center, Dallas, Texas, United States
NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients
Status: Active, not recruiting
Last Changed: Sep 04, 2020
First Received: Sep 04, 2020
Disease(s): Mitochondrial Myopathies
Intervention(s): Niacin
Locations: University of Helsinki, Helsinki, Finland
A Study of the Efficacy and Safety of 24 Week Treatment With REN001 in Patients With Primary Mitochondrial Myopathy
Status: Not yet recruiting
Last Changed: Sep 02, 2020
First Received: Sep 02, 2020
Disease(s): Primary Mitochondrial Myopathy
Intervention(s): REN001, Placebo